344 Phase 3 trial of pembrolizumab and enzalutamide versus enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) (KEYNOTE-641)

Autor:	Arnulf Stenzl, Julie Nicole Graff, Joseph Burgents, Li Wen Liang
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Druh dokumentu:	article
ISSN:	2051-1426
DOI:	10.1136/jitc-2020-SITC2020.0344
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/8428f514bc004bdaa1df05d12549302d Zobrazit plný text záznamu View record in DOAJ